Collegium Pharmaceutical (COLL) PT Raised to $58 at Truist Securities
Tweet Send to a Friend
Truist Securities analyst Gregg Gilbert raised the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $58.00 (from $55.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
